SBC MEDICAL GROUP HOLDINGS I (SBC) Fundamental Analysis & Valuation

NASDAQ:SBC • US73245B1070

Current stock price

3.72 USD
-0.77 (-17.15%)
At close:
3.66 USD
-0.06 (-1.61%)
Pre-Market:

This SBC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. SBC Profitability Analysis

1.1 Basic Checks

  • SBC had positive earnings in the past year.
  • In the past year SBC had a positive cash flow from operations.
  • SBC had positive earnings in 4 of the past 5 years.
  • The reported operating cash flow has been mixed in the past 5 years: SBC reported negative operating cash flow in multiple years.
SBC Yearly Net Income VS EBIT VS OCF VS FCFSBC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 0 20M 40M 60M 80M

1.2 Ratios

  • With an excellent Return On Assets value of 13.40%, SBC belongs to the best of the industry, outperforming 98.00% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of 20.54%, SBC belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 13.29%, SBC belongs to the top of the industry, outperforming 90.00% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for SBC is significantly above the industry average of 8.51%.
  • The 3 year average ROIC (22.12%) for SBC is well above the current ROIC(13.29%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 13.4%
ROE 20.54%
ROIC 13.29%
ROA(3y)15.38%
ROA(5y)N/A
ROE(3y)24.04%
ROE(5y)N/A
ROIC(3y)22.12%
ROIC(5y)N/A
SBC Yearly ROA, ROE, ROICSBC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 0 5 10 15 20 25

1.3 Margins

  • With an excellent Profit Margin value of 29.37%, SBC belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • The Operating Margin of SBC (38.87%) is better than 100.00% of its industry peers.
  • With an excellent Gross Margin value of 73.32%, SBC belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
Industry RankSector Rank
OM 38.87%
PM (TTM) 29.37%
GM 73.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SBC Yearly Profit, Operating, Gross MarginsSBC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. SBC Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), SBC is creating value.
  • Compared to 1 year ago, SBC has about the same amount of shares outstanding.
  • The debt/assets ratio for SBC is higher compared to a year ago.
SBC Yearly Shares OutstandingSBC Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 20M 40M 60M 80M 100M
SBC Yearly Total Debt VS Total AssetsSBC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 4.20 indicates that SBC is not in any danger for bankruptcy at the moment.
  • SBC's Altman-Z score of 4.20 is fine compared to the rest of the industry. SBC outperforms 79.00% of its industry peers.
  • The Debt to FCF ratio of SBC is 1.93, which is an excellent value as it means it would take SBC, only 1.93 years of fcf income to pay off all of its debts.
  • With a decent Debt to FCF ratio value of 1.93, SBC is doing good in the industry, outperforming 76.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.14 indicates that SBC is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.14, SBC is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.93
Altman-Z 4.2
ROIC/WACC1.56
WACC8.51%
SBC Yearly LT Debt VS Equity VS FCFSBC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • SBC has a Current Ratio of 3.78. This indicates that SBC is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of SBC (3.78) is better than 88.00% of its industry peers.
  • A Quick Ratio of 3.74 indicates that SBC has no problem at all paying its short term obligations.
  • SBC has a Quick ratio of 3.74. This is amongst the best in the industry. SBC outperforms 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 3.78
Quick Ratio 3.74
SBC Yearly Current Assets VS Current LiabilitesSBC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SBC Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 19.81% over the past year.
  • SBC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 131.30% yearly.
  • SBC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -15.48%.
EPS 1Y (TTM)19.81%
EPS 3Y131.3%
EPS 5YN/A
EPS Q2Q%-26.32%
Revenue 1Y (TTM)-15.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.93%

3.2 Future

  • SBC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.01% yearly.
  • Based on estimates for the next years, SBC will show a small growth in Revenue. The Revenue will grow by 3.52% on average per year.
EPS Next Y-9.99%
EPS Next 2Y0.5%
EPS Next 3Y1.01%
EPS Next 5YN/A
Revenue Next Year-0.06%
Revenue Next 2Y4.22%
Revenue Next 3Y3.52%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
SBC Yearly Revenue VS EstimatesSBC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 50M 100M 150M 200M
SBC Yearly EPS VS EstimatesSBC Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 0.2 0.4 0.6

More info and screens

Find the best growth stocksShow best growing peers

7

4. SBC Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.59 indicates a rather cheap valuation of SBC.
  • Compared to the rest of the industry, the Price/Earnings ratio of SBC indicates a rather cheap valuation: SBC is cheaper than 97.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 27.95, SBC is valued rather cheaply.
  • With a Price/Forward Earnings ratio of 8.43, the valuation of SBC can be described as very reasonable.
  • 95.00% of the companies in the same industry are more expensive than SBC, based on the Price/Forward Earnings ratio.
  • SBC's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.68.
Industry RankSector Rank
PE 7.59
Fwd PE 8.43
SBC Price Earnings VS Forward Price EarningsSBC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SBC is valued cheaper than 97.00% of the companies in the same industry.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of SBC indicates a somewhat cheap valuation: SBC is cheaper than 71.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.11
EV/EBITDA 3.71
SBC Per share dataSBC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

  • The decent profitability rating of SBC may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0.5%
EPS Next 3Y1.01%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SBC Dividend Analysis

5.1 Amount

  • SBC does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SBC Fundamentals: All Metrics, Ratios and Statistics

SBC MEDICAL GROUP HOLDINGS I

NASDAQ:SBC (4/20/2026, 8:00:02 PM)

Premarket: 3.66 -0.06 (-1.61%)

3.72

-0.77 (-17.15%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-27
Earnings (Next)05-14
Inst Owners1.3%
Inst Owner ChangeN/A
Ins Owners85.22%
Ins Owner Change0%
Market Cap381.60M
Revenue(TTM)173.61M
Net Income(TTM)50.99M
Analysts82.86
Price Target8.29 (122.85%)
Short Float %1.52%
Short Ratio6.38
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.76%
Min EPS beat(2)8.01%
Max EPS beat(2)15.51%
EPS beat(4)3
Avg EPS beat(4)6.8%
Min EPS beat(4)-85.33%
Max EPS beat(4)89.02%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-8.97%
Min Revenue beat(2)-13.79%
Max Revenue beat(2)-4.16%
Revenue beat(4)0
Avg Revenue beat(4)-7.74%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-3.99%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.51%
PT rev (3m)-0.51%
EPS NQ rev (1m)-2%
EPS NQ rev (3m)-2%
EPS NY rev (1m)-11.78%
EPS NY rev (3m)-11.78%
Revenue NQ rev (1m)-7.65%
Revenue NQ rev (3m)-7.65%
Revenue NY rev (1m)-5.12%
Revenue NY rev (3m)-6.27%
Valuation
Industry RankSector Rank
PE 7.59
Fwd PE 8.43
P/S 2.2
P/FCF 17.11
P/OCF 15.47
P/B 1.54
P/tB 2.06
EV/EBITDA 3.71
EPS(TTM)0.49
EY13.17%
EPS(NY)0.44
Fwd EY11.86%
FCF(TTM)0.22
FCFY5.84%
OCF(TTM)0.24
OCFY6.46%
SpS1.69
BVpS2.42
TBVpS1.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number5.16572 (38.86%)
Profitability
Industry RankSector Rank
ROA 13.4%
ROE 20.54%
ROCE 21.13%
ROIC 13.29%
ROICexc 27.34%
ROICexgc 46.1%
OM 38.87%
PM (TTM) 29.37%
GM 73.32%
FCFM 12.84%
ROA(3y)15.38%
ROA(5y)N/A
ROE(3y)24.04%
ROE(5y)N/A
ROIC(3y)22.12%
ROIC(5y)N/A
ROICexc(3y)40.49%
ROICexc(5y)N/A
ROICexgc(3y)50.1%
ROICexgc(5y)N/A
ROCE(3y)35.17%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.93
Debt/EBITDA 0.48
Cap/Depr 88.29%
Cap/Sales 1.37%
Interest Coverage 420.21
Cash Conversion 35.16%
Profit Quality 43.74%
Current Ratio 3.78
Quick Ratio 3.74
Altman-Z 4.2
F-Score4
WACC8.51%
ROIC/WACC1.56
Cap/Depr(3y)89.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.94%
Cap/Sales(5y)N/A
Profit Quality(3y)60.27%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.81%
EPS 3Y131.3%
EPS 5YN/A
EPS Q2Q%-26.32%
EPS Next Y-9.99%
EPS Next 2Y0.5%
EPS Next 3Y1.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.48%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-10.93%
Revenue Next Year-0.06%
Revenue Next 2Y4.22%
Revenue Next 3Y3.52%
Revenue Next 5YN/A
EBIT growth 1Y-20.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-2.19%
EBIT Next 3Y3.82%
EBIT Next 5YN/A
FCF growth 1Y29.83%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y19.85%
OCF growth 3YN/A
OCF growth 5YN/A

SBC MEDICAL GROUP HOLDINGS I / SBC Fundamental Analysis FAQ

What is the fundamental rating for SBC stock?

ChartMill assigns a fundamental rating of 6 / 10 to SBC.


Can you provide the valuation status for SBC MEDICAL GROUP HOLDINGS I?

ChartMill assigns a valuation rating of 6 / 10 to SBC MEDICAL GROUP HOLDINGS I (SBC). This can be considered as Fairly Valued.


Can you provide the profitability details for SBC MEDICAL GROUP HOLDINGS I?

SBC MEDICAL GROUP HOLDINGS I (SBC) has a profitability rating of 7 / 10.


What are the PE and PB ratios of SBC MEDICAL GROUP HOLDINGS I (SBC) stock?

The Price/Earnings (PE) ratio for SBC MEDICAL GROUP HOLDINGS I (SBC) is 7.59 and the Price/Book (PB) ratio is 1.54.


Can you provide the expected EPS growth for SBC stock?

The Earnings per Share (EPS) of SBC MEDICAL GROUP HOLDINGS I (SBC) is expected to decline by -9.99% in the next year.